Recruiting studies: Multiple Sclerosis Relapsing Forms Of Multiple Sclerosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
Phase 4 · 1 location(s) · Northwestern University · NCT07225361 A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Fo
Phase 1 · 1 location(s) · Stanford University · NCT06138132 Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis
Phase 2/Phase 3 · 2 location(s) · TG Therapeutics, Inc. · NCT07220252 Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
Phase N/A · 7 location(s) · Biogen · NCT05658497 A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Mul
Phase N/A · 1 location(s) · Neurology Center of New England P.C. · NCT06681623 A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms
Phase 1 · 35 location(s) · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · NCT06220201

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.